MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
and sales of...
$1,033,259K
Net proceeds from
stock option...
$8,676K
Net cash provided by
investing activities
$377,184K
Net cash provided by
financing activities
$8,676K
Canceled cashflow
$656,075K
Net change in cash
and cash...
$12,883K
Canceled cashflow
$372,977K
Purchases of marketable
securities
$641,759K
Payments associated with
license agreement
$10,000K
Purchases of property and
equipment
$4,316K
Stock-based compensation
expense
$52,552K
Non-cash operating lease
expense
$12,425K
Expense associated with
license agreement
$10,000K
Depreciation and
amortization
$5,177K
Accounts payable
$1,746K
Loss (gain) on
disposal of property and...
-$5K
Net cash used in
operating activities
-$372,977K
Canceled cashflow
$81,905K
Net (loss) income
-$412,781K
Operating lease
liabilities
-$16,781K
Net accretion of
discount on marketable...
$7,195K
Accounts receivable, net
$6,468K
Inventory
$5,304K
Prepaid expenses and
other current and...
$3,172K
Accrued expenses
-$1,402K
Income taxes payable
-$871K
Other liabilities
-$790K
Realized gain on
investments
$118K
Back
Back
Cash Flow
source: myfinsight.com
AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. (AGIO)